About: Didier Betbeder

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Didier Betbeder Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Didier Betbeder (en) Didier Betbeder (es) Didier Betbeder (nl) Didier Betbeder (ast)
skos:prefLabel	Didier Betbeder (en) Didier Betbeder (es) Didier Betbeder (nl) Didier Betbeder (ast)
name	Didier Betbeder (en) Didier Betbeder (es) Didier Betbeder (nl) Didier Betbeder (ast)
given name	wds:Q57041630-89AF49A4-FB3A-4A96-9D0F-0BC647039834
given name	Didier
instance of	wds:Q57041630-48A09D23-C062-4882-9E83-6D506551B9D7
instance of	Homo sapiens
doctoral student	wds:Q57041630-F4987E2E-63EE-4AAC-B94A-F8C597D81AB5
doctoral student	Alexandre Marles
occupation	wds:Q57041630-EAEDCCAF-23ED-41A2-9514-932829B63ABD
employer	wds:Q57041630-11FD71DC-4742-4C1A-B556-64B89A9D87A1 wds:Q57041630-3716632B-2AE6-4878-946E-D60A760138B0
sex or gender	wds:Q57041630-9EDBA770-5031-4153-8D2F-7D9209DA83DA
ISNI	wds:Q57041630-6D2EED6E-85B9-42CF-9F52-05D2E3604A0B
VIAF ID	wds:Q57041630-71FD52D3-3FC6-4DB2-8A4B-B094C4684A63
IdRef ID	wds:Q57041630-30E9DA08-38C8-4288-AA41-49E7A17EE2B8
date of birth	wds:Q57041630-154CDC35-390B-4975-BFB6-0EE3BB416FF8
WorldCat Identities ID (superseded)	wds:Q57041630-4DDAACCF-DEEF-4852-AE90-E7554FBE8B66
VIAF ID	http://viaf.org/viaf/297149421
IdRef ID	http://www.idref.fr/03351674X/id
occupation	researcher
employer	Artois University University of Warwick
sex or gender	male
ISNI	0000000401974560
VIAF ID	297149421
IdRef ID	03351674X
date of birth	1958-01-01 00:00:00Z (xsd:dateTime)
WorldCat Identities ID (superseded)	lccn-no2019143429
ORCID iD	wds:Q57041630-E602ABA0-E615-4521-BD8B-7C63FBDBDBDB
Dimensions author ID	wds:Q57041630-D419A4BC-E2C0-42A5-8906-C33D03BC86D6
ORCID iD	https://orcid.org/0000-0002-2405-392X
ORCID iD	0000-0002-2405-392X
Dimensions author ID	01207672417.90
ResearcherID	wds:Q57041630-F2EB782A-DB7B-46A6-84C6-7E06DDF5B236
ResearcherID	A-7558-2015
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57041630
is author of	Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma. HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis Drug delivery systems in the treatment of African trypanosomiasis infections Development of a nanoparticulate formulation of diminazene to treat African trypanosomiasis Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma Versatile enzymatic diacid ester synthesis of butyl α-D-glucopyranoside Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells. Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration Biovector nanoparticles improve antinociceptive efficacy of nasal morphine Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers Characterisation and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles Effect of prior heavy exercise on muscle deoxygenation kinetics at the onset of subsequent heavy exercise. Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65 Chapter 1 - Drug delivery to the brain using colloidal carriers. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells Airway delivery of peptides and proteins using nanoparticles Study of serum interaction with a cationic nanoparticle: Implications for in vitro endocytosis, cytotoxicity and genotoxicity Stabilization of human tyrosine hydroxylase in maltodextrin nanoparticles for delivery to neuronal cells and tissue. Nasal nanovaccines New methods to determine the extent of reaction of epichlorohydrin with maltodextrins A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens. Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ T-cell clones in vitro. Separation of dipalmitoyl phosphatidyl choline, cholesterol and their degradation products by high-performance liquid chromatography on a perfluorinated stationary bonded phase Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors Antimicrobials. New nitrofuran derivatives Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles. Development and validation of a reversed-phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software